HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 166 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,538,000 | -30.2% | 120,000 | -29.4% | 0.22% | -36.7% |
| Q1 2017 | $2,203,000 | +23.9% | 170,000 | -5.6% | 0.35% | +2.3% |
| Q4 2016 | $1,778,000 | -99.9% | 180,000 | -28.0% | 0.34% | -29.0% |
| Q3 2016 | $3,020,000,000 | +139844.4% | 250,000 | 0.0% | 0.48% | +25.3% |
| Q2 2016 | $2,158,000 | -47.1% | 250,000 | -42.0% | 0.38% | -52.7% |
| Q1 2016 | $4,082,000 | -42.5% | 431,000 | +5.1% | 0.81% | -24.6% |
| Q4 2015 | $7,105,000 | +207.6% | 410,000 | +138.4% | 1.07% | +191.8% |
| Q3 2015 | $2,310,000 | -40.5% | 172,000 | 0.0% | 0.37% | -21.0% |
| Q2 2015 | $3,884,000 | – | 172,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |